La Dieta Cetogénica o Dieta “Ceto” ha crecido en popularidad durante los últimos veinte años. Es una dieta natural que ha sido implementada por varias tribus y pueblos de todo el mundo durante miles de años y se ha utilizado como un medio para controlar la epilepsia. La Dieta Cetogénica comenzó cuando se descubrió en la década de 1920 que las mejoras en la actividad epiléptica comenzaron unos días después de que se agotaron las reservas de glucógeno. El individuo cambió a usar cetonas para obtener energía. Luego se sugirió que las personas con epilepsia podrían obtener los mismos beneficios neuroprotectores si comían una dieta que los mantuviera en un estado de cetosis sin tener que ayunar. En respuesta a esta información, los médicos comenzaron a prescribir una dieta con un 85-90% de grasa, con el resto de las calorías provenientes principalmente de proteínas y pocos carbohidratos y, por lo tanto, nació la Dieta Ceto.
Conklin's fasting therapy was adopted by neurologists in mainstream practice. In 1916, a Dr McMurray wrote to the New York Medical Journal claiming to have successfully treated epilepsy patients with a fast, followed by a starch- and sugar-free diet, since 1912. In 1921, prominent endocrinologist Henry Rawle Geyelin reported his experiences to the American Medical Association convention. He had seen Conklin's success first-hand and had attempted to reproduce the results in 36 of his own patients. He achieved similar results despite only having studied the patients for a short time. Further studies in the 1920s indicated that seizures generally returned after the fast. Charles P. Howland, the parent of one of Conklin's successful patients and a wealthy New York corporate lawyer, gave his brother John Elias Howland a gift of $5,000 to study "the ketosis of starvation". As professor of paediatrics at Johns Hopkins Hospital, John E. Howland used the money to fund research undertaken by neurologist Stanley Cobb and his assistant William G. Lennox.
Funciona la dieta ceto
A study with an intent-to-treat prospective design was published in 1998 by a team from the Johns Hopkins Hospital and followed-up by a report published in 2001. As with most studies of the ketogenic diet, no control group (patients who did not receive the treatment) was used. The study enrolled 150 children. After three months, 83% of them were still on the diet, 26% had experienced a good reduction in seizures, 31% had had an excellent reduction, and 3% were seizure-free.[Note 7] At 12 months, 55% were still on the diet, 23% had a good response, 20% had an excellent response, and 7% were seizure-free. Those who had discontinued the diet by this stage did so because it was ineffective, too restrictive, or due to illness, and most of those who remained were benefiting from it. The percentage of those still on the diet at two, three, and four years was 39%, 20%, and 12%, respectively. During this period, the most common reason for discontinuing the diet was because the children had become seizure-free or significantly better. At four years, 16% of the original 150 children had a good reduction in seizure frequency, 14% had an excellent reduction, and 13% were seizure-free, though these figures include many who were no longer on the diet. Those remaining on the diet after this duration were typically not seizure-free, but had had an excellent response.